NCT07349940 Early Detection of Skin Tumors Using a Telemedicine Tool in Primary Care
| NCT ID | NCT07349940 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Institute of Health Information and Statistics of the Czech Republic |
| Condition | Skin Cancer Prevention |
| Study Type | INTERVENTIONAL |
| Enrollment | 1,440 participants |
| Start Date | 2026-02-01 |
| Primary Completion | 2026-08 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 1,440 participants in total. It began in 2026-02-01 with a primary completion date of 2026-08.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The project is a national, prospective, multicenter, single-arm interventional pilot of screening skin tumors in the Czech Republic. The primary aim of the project is to methodically prepare, implement and evaluate a pilot project that will verify the suitability of the proposed procedure of early detection of skin tumors by using a telemedicine tools and setting up and testing new methods and implementation into the system of social health care.
Eligibility Criteria
Inclusion Criteria: * at least 1 suspected lession * phototype I or phototype II Exclusion Criteria: * skin lession examination by dermatologist in last 12 months * unsigned consent to participate in the project and consent to the processing of personal data
Contact & Investigator
Petr Arenberger, prof.
STUDY DIRECTOR
Hospital university Kralovske Vinohrady
Frequently Asked Questions
Who can join the NCT07349940 clinical trial?
This trial is open to participants of all sexes, aged 50 Years or older, studying Skin Cancer Prevention. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07349940 currently recruiting?
Yes, NCT07349940 is actively recruiting participants. Contact the research team at dagmar.obsilova@uzis.cz for enrollment information.
Where is the NCT07349940 trial being conducted?
This trial is being conducted at Brno, Czechia, Olomouc, Czechia, Pilsen, Czechia, Prague, Czechia and 1 additional location.
Who is sponsoring the NCT07349940 clinical trial?
NCT07349940 is sponsored by Institute of Health Information and Statistics of the Czech Republic. The principal investigator is Petr Arenberger, prof. at Hospital university Kralovske Vinohrady. The trial plans to enroll 1,440 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.